Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

…, L Levanov, L Szirovicza, A Tobi, H Kallio-Kokko… - Science, 2020 - science.org
The causative agent of coronavirus disease 2019 (COVID-19) is the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). For many viruses, tissue tropism is determined by …

[HTML][HTML] Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020

…, A Kantele, T Strandin, H Kallio-Kokko… - …, 2020 - eurosurveillance.org
The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January
2020. No secondary cases were detected. We describe the clinical picture and laboratory …

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

…, MJ Ahava, R Loginov, H Kallio-Kokko… - Journal of Clinical …, 2020 - Elsevier
There is an urgent need for reliable high-throughput serological assays for the management
of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a …

Tula virus: a newly detected hantavirus carried by European common voles

…, N Apekina, Y Myasnikov, H Kallio-Kokko… - Journal of …, 1994 - Am Soc Microbiol
A novel hantavirus has been discovered in European common voles, Microtus arvalis and
Microtus rossiaemeridionalis. According to sequencing data for the genomic RNA S segment …

Human B‐cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response

O Vapalahti, H KallioKokko… - Journal of medical …, 1995 - Wiley Online Library
Puumala virus (PUU) is a member of the Hantavi rus genus in the family Bunyaviridae and
the etiologic agent of nephropathia epidemica (NE), a form of haemorrhagic fever with renal …

Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system

…, L Levanov, L Szirovicza, A Tobi, H Kallio-Kokko… - BioRxiv, 2020 - biorxiv.org
The causative agent of the current pandemic and coronavirus disease 2019 (COVID-19) is
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 . Understanding how …

[HTML][HTML] Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples

…, E Kekäläinen, H Kallio-Kokko… - …, 2020 - eurosurveillance.org
Antibody-screening methods to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
need to be validated. We evaluated SARS-CoV-2 IgG and IgA ELISAs in …

[HTML][HTML] Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

…, A Järvinen, P Jokela, H Kallio-Kokko… - PloS one, 2021 - journals.plos.org
Background Understanding the false negative rates of SARS-CoV-2 RT-PCR testing is
pivotal for the management of the COVID-19 pandemic and it has implications for patient …

[HTML][HTML] Zika virus infection in a traveller returning from the Maldives, June 2015

…, E Huhtamo, T Smura, H Kallio-Kokko… - …, 2016 - eurosurveillance.org
We report a Zika virus (ZIKV) infection in a patient with fever and rash after returning to Finland
from Maldives, June 2015. The patient had dengue virus (DENV) IgG and IgM antibodies …

[HTML][HTML] Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010–2018

A Ianevski, E Zusinaite, N Shtaida, H Kallio-Kokko… - Viruses, 2019 - mdpi.com
With the increasing pace of global warming, it is important to understand the role of
meteorological factors in influenza virus (IV) epidemics. In this study, we investigated the impact of …